-
The human urokinase-plasminogen activator gene and its promoter.
Nucleic Acids Res. 1985 Apr 25;13(8):2759-71
PMID: 2987867
-
Plasminogen activation: biochemistry, physiology, and therapeutics.
Crit Rev Biotechnol. 1988;8(2):131-48
PMID: 2976309
-
Integration of hepatitis B virus DNA into cells of six established human hepatocellular carcinoma cell lines.
Hepatogastroenterology. 1990 Oct;37(5):457-60
PMID: 1701409
-
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.
Science. 1991 Feb 15;251(4995):802-4
PMID: 1846706
-
Growth factors in the regulation of plasminogen-plasmin system in tumor cells.
Semin Thromb Hemost. 1991 Jul;17(3):231-9
PMID: 1839081
-
Hepatocyte growth factor concentrations after liver resection.
Lancet. 1992 Mar 28;339(8796):818
PMID: 1347849
-
cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
J Immunol. 1992 Jun 1;148(11):3636-42
PMID: 1316922
-
Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species.
Exp Cell Res. 1992 Oct;202(2):423-31
PMID: 1327854
-
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.
J Cell Biol. 1992 Nov;119(3):629-41
PMID: 1383237
-
Biology and biochemistry of proteinases in tumor invasion.
Physiol Rev. 1993 Jan;73(1):161-95
PMID: 8419965
-
Reverse transcription-polymerase chain reaction phenotyping of metalloproteinases and inhibitors involved in tumor matrix invasion.
Diagn Mol Pathol. 1993 Jun;2(2):74-80
PMID: 8269280
-
Tumor cell interactions with the extracellular matrix during invasion and metastasis.
Annu Rev Cell Biol. 1993;9:541-73
PMID: 8280471
-
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Nature. 1994 Jul 7;370(6484):61-5
PMID: 8015608
-
Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan.
Cancer. 1994 Nov 15;74(10):2772-80
PMID: 7954236
-
Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases.
Hepatology. 1995 Dec;22(6):1728-34
PMID: 7489981
-
Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Cancer Res. 1996 Jan 15;56(2):384-92
PMID: 8542596
-
Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
Hepatology. 1996 Aug;24(2):316-22
PMID: 8690399
-
Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas.
J Cell Biochem. 1996 Sep 15;62(4):443-53
PMID: 8891890
-
Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
Hepatology. 1996 Nov;24(5):1058-62
PMID: 8903375
-
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
Cell Growth Differ. 1996 Nov;7(11):1513-23
PMID: 8930401
-
Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel.
Clin Exp Metastasis. 1996 Nov;14(6):520-9
PMID: 8970582
-
Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma.
Hepatology. 1997 Jan;25(1):87-92
PMID: 8985270
-
Participation of c-met in the progression of human gastric cancers: anti-c-met oligonucleotides inhibit proliferation or invasiveness of gastric cancer cells.
Cancer Gene Ther. 1996 Nov-Dec;3(6):393-404
PMID: 8988842
-
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
J Biol Chem. 1997 Jan 24;272(4):2446-51
PMID: 8999957
-
Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
Hepatology. 1997 Apr;25(4):862-6
PMID: 9096589
-
Relation of enhanced secretion of active matrix metalloproteinases with tumor spread in human hepatocellular carcinoma.
Gastroenterology. 1997 Apr;112(4):1290-6
PMID: 9098015
-
A modified and convenient method for assessing tumor cell invasion and migration and its application to screening for inhibitors.
Biol Pharm Bull. 1997 Apr;20(4):345-8
PMID: 9145207
-
Results of 90 consecutive hepatectomies for hepatocellular carcinoma: a multivariate analysis of survival.
Semin Oncol. 1997 Apr;24(2 Suppl 6):S6-1-6
PMID: 9151909
-
Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells.
Oncol Res. 1996;8(12):503-11
PMID: 9160354
-
The urokinase-type plasminogen activator system in cancer metastasis: a review.
Int J Cancer. 1997 Jul 3;72(1):1-22
PMID: 9212216
-
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Cancer Res. 1997 Aug 1;57(15):3305-13
PMID: 9242465
-
Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study.
Jpn J Clin Oncol. 1997 Aug;27(4):251-7
PMID: 9379514
-
Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines.
Int J Oncol. 1998 Mar;12(3):655-9
PMID: 9472107
-
Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro.
Clin Exp Metastasis. 1998 Jan;16(1):74-82
PMID: 9502079
-
Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.
J Hepatol. 1998 Feb;28(2):231-9
PMID: 9514536
-
Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
J Med Chem. 1998 Apr 9;41(8):1209-17
PMID: 9548812
-
Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.
Cancer Res. 1998 May 15;58(10):2234-9
PMID: 9605771
-
Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor.
Int J Urol. 1998 May;5(3):276-81
PMID: 9624561
-
4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals.
Clin Exp Metastasis. 1998 Oct;16(7):633-43
PMID: 9932610
-
Marimastat (BB2516): current status of development.
Cancer Chemother Pharmacol. 1999;43 Suppl:S56-60
PMID: 10357560
-
Changing views of the role of matrix metalloproteinases in metastasis.
J Natl Cancer Inst. 1997 Sep 3;89(17):1260-70
PMID: 9293916